Literature DB >> 1964910

Peripheral kappa-opioid modulation of the formalin response: an electrophysiological study in the rat.

J Haley1, S Ketchum, A Dickenson.   

Abstract

The activity of single dorsal horn nociceptive neurones was recorded in the spinal cord of halothane anaesthetized rats. S.c. injection of a 5% formalin solution into the receptive field of these neurones resulted in two peaks of neuronal firing over a period of 60 min. Prior administration of the kappa-opioid receptor agonist U50488H directly into the site of formalin injection caused a dose-dependent decrease in the size of both the first and second peaks of the response which was naloxone reversible. Injection of U50488H into the contralateral paw had no effect on either peak of the formalin response. Injection of the top dose (100 micrograms) of U50488H had no effect on the electrically evoked A beta- or C-fibre responses of the neurone. Neither morphine nor Tyr-D-Ser(Otbu)-Gly-Phe-Leu-Thr (DSTBULET), administered into the receptive field, had any significant effect on either peak of the formalin response. Plasma extravasation in the skin, measured using Evans blue, produced by the formalin injection was not blocked by U50488H. Thus, whilst the spinal responses of this peripheral model of inflammation can be inhibited by peripheral kappa-opioid activation, but not mu- or delta-, plasma extravasation associated with this inflammation is not reduced.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964910     DOI: 10.1016/0014-2999(90)94178-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.

Authors:  H Rogers; P J Birch; S M Harrison; E Palmer; G R Manchee; D B Judd; A Naylor; D I Scopes; A G Hayes
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.

Authors:  P Honoré; J Buritova; J M Besson
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

4.  The Rostral Agranular Insular Cortex, a New Site of Oxytocin to Induce Antinociception.

Authors:  Mohammed Gamal-Eltrabily; Antonio Espinosa de Los Monteros-Zúñiga; Alfredo Manzano-García; Guadalupe Martínez-Lorenzana; Miguel Condés-Lara; Abimael González-Hernández
Journal:  J Neurosci       Date:  2020-06-22       Impact factor: 6.167

5.  Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.

Authors:  M C Ko; J E Tuchman; M D Johnson; K Wiesenauer; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

6.  Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.

Authors:  C G Jolivalt; Y Jiang; J D Freshwater; G D Bartoszyk; N A Calcutt
Journal:  Diabetologia       Date:  2006-08-19       Impact factor: 10.122

7.  Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.

Authors:  M C H Ko; N N Naughton; J R Traynor; M S Song; J H Woods; K C Rice; A T McKnight
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

8.  Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.

Authors:  A Barber; G D Bartoszyk; H E Greiner; F Mauler; R D Murray; C A Seyfried; M Simon; R Gottschlich; J Harting; I Lues
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

Authors:  A Barber; G D Bartoszyk; H M Bender; R Gottschlich; H E Greiner; J Harting; F Mauler; K O Minck; R D Murray; M Simon
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

10.  Genetic reduction of chronic muscle pain in mice lacking calcium/calmodulin-stimulated adenylyl cyclases.

Authors:  Kunjumon I Vadakkan; Hansen Wang; Shanelle W Ko; Evelyn Zastepa; Michele J Petrovic; Kathleen A Sluka; Min Zhuo
Journal:  Mol Pain       Date:  2006-02-17       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.